Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer

OBJECTIVES: Optimal adjuvant treatment for early-stage clear cell and serous endometrial cancer remains unclear. We report outcomes for women with surgically staged International Federation of Gynecology and Obstetrics (FIGO) stage I clear cell, serous, and mixed endometrial cancers following adjuva...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Gynecol Cancer
Glavni autori: Jeans, Elizabeth B, Breen, William G, Mullikin, Trey C, Looker, Brittany A, Mariani, Andrea, Keeney, Gary L, Haddock, Michael G, Petersen, Ivy A
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8223628/
https://ncbi.nlm.nih.gov/pubmed/33563642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2020-002217
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items